© All rights reserved to Barnea Jaffa Lande Law offices

Search by Practice

Latest Updates /  Corporate

November 10, 2022

The Great Wall of China – Increasing Difficulty in Doing Business with China

The restrictions imposed by the United States are relevant to Israeli companies in at least two ways. First, they are imposed on anyone who is a US citizen or lives in the United States and who deals with regulated products. Second, the Americans have applied the Foreign Direct Product Rule to some of the regulated products and to a list of Chinese companies.

October 27, 2022

Legal Aspects of SAFEs (Simple Agreement for Future Equity)

Since a SAFE is a relatively standard agreement, there is no need for lengthy negotiations on comprehensive investment agreements. A SAFE defines clear rules about the investor’s rights (which include, inter alia, rights similar to those the next investors in the company receive during future rounds of funding).  

October 27, 2022

Barnea Represented Mouro Capital in USD 80 Million Investment in Vesttoo

Ariella Dreyfuss  represented Mouro Capital as the lead investor in an USD 80 million Series C financing round in the Israeli insurtch startup Vesttoo. The investment was based on a company valuation of USD 1 billion. 

October 6, 2022

Barnea: Representing Metuka Bakery in Sale to Adi Cohen, Former CEO of Tiv Ta'am

Ilan Blumenfeld, Yuval Lazi, and Dor Levi-Tam represented the founders of the coffee shop/bakery chain Metuka in the company's sale to businessman Adi Cohen, former CEO of Tiv Ta'am. 

October 3, 2022

Doing Business in Israel: Forming a Limited Liability Company in Israel

The Israeli Companies Law enables local and international businesses to engage in business activity easily and with relative efficiency and The procedure for forming a limited liability company is relatively simple.

October 2, 2022

Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog

Sagi Gross and Dor Levi-Tam represented Pronto Diagnostics and its owners in a transaction to sell control of the company to Novolog. Pronto operates in the field of molecular genetic diagnostics.

September 8, 2022

Barnea: Representing Naveh Pharma and Bigdam Ltd in Sale to Diplomat

The import giant Diplomat has acquired control of the companies Naveh Pharma and Bigdam Ltd for NIS 96 million. Advs. Sagi Gross, Dor Levi-Tam, and Izabel Pashayev successfully represented the companies and their owners in the transaction.

September 8, 2022

Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million

Neve Pharma is engaged in the development, marketing, and sale of nutritional supplements, as well as medical accessories in the ENT field. Sixty-five percent of the company was recently sold to the public company Diplomat for NIS 81 million. Neve Pharma was represented by Sagi Gross, Dor Levi-Tam, and Izabel Pashayev in the transaction. 

August 15, 2022

Barnea Representing Migdal in Investment in Major European Infrastructure Project

Roy Engel and Yakov Vilenski represented Migdal in a NIS 130 million investment in one of the biggest infrastructure projects in Europe: the NeuConnect Interconnector. This project consists of a 725 km submarine power transmission line that will connect the English power grid with the German power grid for the first time. The investment agreement was signed with the French fund MIE III Co-Investment Fund II S.L.P.

July 14, 2022

Doing Business in Israel: How to Take Part in Israeli Innovation

Israel boasts a unique combination of academic excellence and an entrepreneurial approach. As a result, it is the home base for many startup companies. Most technologies underpinning startup companies develop at academic institutions.

July 11, 2022

Proud to Represent Cibus Fund in Biotech Company Investment

Barnea represented Cibus Fund in an investment in Phytolon, a biotech company that develops fermentation-based natural food colors.

July 7, 2022

Guide to the ESGI

Everyone agrees ESG principles are important aspects of companies’ activities, but these principles have also received considerable criticism. This criticism is not of the principles themselves, but rather is directed against companies that exploit these principles for the purposes of public relations and image-building. Such criticism also spotlights the considerable difficulties in implementing fundamental changes in business activities.

June 28, 2022

Barnea Represents Azrieli in Data Center Acquisition

We represented Azrieli Group in the acquisition of a London data center operator for GBP 52 million. The acquisition is part of Azrieli's expansion in the data center sector. Ariella Dreyfuss, Mayer Winkler, and Tal Freilich provided representation in the transaction.

June 22, 2022

District Court: Changing a Business Model after Purchasing Company Shares Does not Always Constitute a Tax Event

The Israeli court's ruling further details and explains the complicated tax issues that may arise from business restructuring and from transactions that create such restructuring.  

June 8, 2022

Sagi Gross Lectures to Bar-Ilan University’s Law and Environment Club

As part of our ongoing collaboration with Bar-Ilan University’s Law and Environment Club, Adv. Sagi Gross lectured to students of  on the environmental aspects of MA transactions. He discussed due diligence processes, indemnity mechanisms, ESG investments, and more.

June 2, 2022

Kedma Capital acquires "Zriha Hlavin Industries"

Adv. Ilan Blumenfeld, Hagit Ross and Dor Levi-Tam represented the sellers in the transaction for the sale of all their shares in Zriha Hlavin to Kedma Capital.

May 26, 2022

SightVision Completes Acquisition of Terravision

SightVision Information Systems Ltd. has completed a 100% acquisition of Terravision Ltd., which develops applications and provides services in the geographical field, and has been developing advanced mapping systems for over 30 years. SightVision also completed the acquisition of 100% of the rights in the partnership Terra-Design 3D Mapping, which provides 3D modeling services. Advs. Ilan Blumenfeld and Dor Levi-Tam represented SightVision in the transaction.

May 24, 2022

Danel Acquires Additional 10% of Enaim Medical Center

The NIS 43 million acquisition will make Danel the owner of 61% of Enaim Medical Center. Advs. Ilan Blumenfeld and Daniel Kleinman represented Danel in the transaction.

May 22, 2022

BioGenCell Completes USD 16 Million Seed Round

Our firm represents BioGenCell, a stem cell research and development company located at Laniado Hospital. The company recently announced the completion of a USD 16 million seed round investment, aided by counsel from Advs. Itay Gura and Inbar Katzir. Our firm has represented the company since its inception.

April 14, 2022

Migdal Group invests in Scandinavian energy

Migdal Group has invested, together with other partnerships, in the alternative energy projects of Fu-Gen AG and Fu-Gen Assets 4 AB. Firm partners Micky Barnea, Ariella Dreyfuss, and Roy Engel advised on the NIS 1 billion investment.